Martín Redrado
President of the Central Bank of Argentina (2004–2010); Director of Fundación Capital and of the Master in Central Banking at Asia Business School (Malaysia)
2011 Nobel Laureate in Physiology or Medicine | Discoverer of the Toll Immune Pathway | Professor, University of Strasbourg | Former President, French Academy of Sciences
Jules Hoffmann cracked the molecular code of innate immunity — the billion-year-old defense system all animals share. His Nobel-winning discovery of the Toll pathway in fruit flies transformed immunology, seeding breakthroughs in cancer therapy, vaccines, and sepsis treatment. A charismatic and intellectually generous speaker, he makes the deepest questions in biology feel urgent and accessible to any senior audience.
Want to book Jules Hoffmann as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Jules A. Hoffmann is a Luxembourgish-French biologist and 2011 Nobel Laureate in Physiology or Medicine whose work on the fruit fly Drosophila revealed the molecular architecture of innate immunity — the ancient, universal first line of defense that all living organisms deploy against infection. Professor of Integrative Biology at the University of Strasbourg Institute for Advanced Study, Emeritus Research Director at France’s CNRS, and former President of the French Academy of Sciences, Hoffmann occupies a singular position in global science: the man who cracked the immune code in insects and, in doing so, transformed our understanding of immunity across all animal life.
Now part of Aurum’s Nobel Prize speakers, Jules Hoffmann spent decades studying how insects resist infection — a question that struck him as a student when he marveled at grasshoppers’ apparent imperviousness to disease. Working at CNRS in Strasbourg, he founded and directed the Immune Response and Development in Insects unit in 1978, building a research program that would, nearly two decades later, change immunology forever. In 1996, together with collaborator Bruno Lemaitre, Hoffmann demonstrated that the Toll gene — previously known only for its role in embryonic development — was the master switch of antifungal immunity in the fly. Flies with Toll mutations could not fight off infection and died. The Toll pathway, it turned out, was not a quirk of insect biology: it was an evolutionarily conserved system shared across hundreds of millions of years of animal life.
That discovery directly inspired Bruce Beutler’s identification of Toll-like receptor 4 (TLR4) in mammals, completing a picture that showed how the same molecular logic governs immune sensing from flies to humans. The downstream implications have been profound — from new therapeutic strategies in sepsis and cancer immunotherapy to the rational design of vaccine adjuvants. Hoffmann’s work also triggered the identification of more than a dozen distinct Toll-like receptors in humans and mice, each recognizing signature molecules of different classes of pathogens.
The breadth of Hoffmann’s recognition reflects the magnitude of his contribution. In addition to the Nobel Prize, he received the CNRS Gold Medal — France’s highest scientific distinction — the Shaw Prize in Life Science and Medicine, and the Canada Gairdner International Award. He served as President of the French Academy of Sciences and has been elected to the U.S. National Academy of Sciences, the American Academy of Arts and Sciences, the German Academy of Sciences Leopoldina, and the Russian Academy of Sciences. France named him a Commander of the Legion of Honour.
As a speaker, Jules Hoffmann brings a rare gift: the ability to guide audiences — from life sciences executives and policy-makers to curious non-specialists — through the deepest questions in biology with warmth, clarity, and narrative drive. His talks move between the wonder of basic science and its tangible human stakes, from the fruit fly lab to the frontiers of cancer and infectious disease. Known for his charismatic and intellectually generous platform presence, he offers senior audiences both the sweep of evolutionary biology and the strategic implications for healthcare, drug discovery, and pandemic preparedness that follow from understanding how immunity actually works.
In this signature keynote, Hoffmann recounts the scientific journey that led from a student's curiosity about why grasshoppers don't get sick to a discovery that rewrote immunology. He explains how the Toll gene in fruit flies revealed a conserved molecular system for sensing infection that operates from insects to humans, and why understanding this system is reshaping how medicine approaches everything from sepsis and autoimmune disease to cancer. Compelling for life sciences, healthcare, and broadly curious leadership audiences.
Biology's greatest secret may be how much the immune systems of a fruit fly and a human have in common. Hoffmann explores the deep evolutionary architecture of innate immunity — how hundreds of millions of years of natural selection produced a molecular toolkit remarkably conserved across species — and what this continuity reveals about new strategies for combating infection, inflammation, and cancer. A powerful talk for audiences in biotech, pharmaceutical R&D, and science policy.
No one set out to revolutionize medicine by studying flies. Hoffmann reflects on the unexpected arc of his career — how following scientific curiosity without a predetermined destination led to a Nobel Prize and a cascade of clinical breakthroughs. Drawing on decades at the frontier of research, he offers leaders a framework for building organizations that make room for exploration, tolerate uncertainty, and convert long-horizon thinking into transformative results. Ideal for innovation-focused executive audiences across all industries.
The discoveries Hoffmann and his contemporaries made about how the immune system detects pathogens are now central to some of the most promising frontiers in medicine — from next-generation vaccine adjuvants and checkpoint immunotherapy to early warning systems for pandemic threats. Hoffmann maps this landscape for senior decision-makers, connecting foundational science to near-term therapeutic and public health opportunities, and exploring what the next decade of immunity research may deliver.
| Basic Data Protection Information | |
|---|---|
| Data controller | AURUM SPEAKERS BUREAU S.L. |
| Address | Parc Audiovisual de Catalunya 1, Oficina S11, 08225 Terrassa, Spain |
| Purposes | We will use your data to respond to your requests and deliver our services to you. |
| Marketing | We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Lawful basis | We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Recipients | Generally, only our members of staff who have been duly authorised may access the data that you have provided. |
| Your Rights | You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website. |
| Additional Information | For more information, please see “PRIVACY POLICY” on our website. |